Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HEPSERA for Chronic hepatitis b: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 19 adverse event reports in the FDA FAERS database where HEPSERA was used for Chronic hepatitis b.

Most Reported Side Effects for HEPSERA

Side Effect Reports % Deaths Hosp.
Osteomalacia 15 27.3% 1 10
Hypophosphataemia 14 25.5% 1 8
Fanconi syndrome acquired 11 20.0% 1 4
Drug resistance 10 18.2% 1 2
Hepatitis b dna increased 10 18.2% 0 1
Arthralgia 9 16.4% 1 5
Blood phosphorus decreased 9 16.4% 0 4
Back pain 8 14.6% 0 5
Drug ineffective 8 14.6% 0 0
Bone pain 7 12.7% 0 4
Renal impairment 7 12.7% 0 2
Pain 6 10.9% 0 4
Pain in extremity 6 10.9% 0 2
Condition aggravated 5 9.1% 0 3
Muscular weakness 5 9.1% 0 4

Other Indications for HEPSERA

Hepatitis b (26)

Other Drugs Used for Chronic hepatitis b

TENOFOVIR DISOPROXIL (1,156) LAMIVUDINE (998) ADEFOVIR DIPIVOXIL (776) ENTECAVIR (705) TENOFOVIR ALAFENAMIDE (679) PEGINTERFERON ALFA-2A (234) TENOFOVIR (187) TELBIVUDINE (153) ADEFOVIR (77) EMTRICITABINE\TENOFOVIR DISOPROXIL (34)

Related Pages

HEPSERA Full Profile All Chronic hepatitis b Drugs HEPSERA Demographics HEPSERA Timeline